XML 49 R37.htm IDEA: XBRL DOCUMENT v3.22.1
Product Revenue, Net - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Dec. 31, 2021
Disaggregation of Revenue [Line Items]      
Revenue $ 468 $ 6,582  
Gross-to-net sales accruals $ 154 0 $ 0
Gross product revenue | Customer | AmerisourceBergen Drug Corporation      
Disaggregation of Revenue [Line Items]      
Concentration risk (percent) 17.10%    
Gross product revenue | Customer | Cardinal Health      
Disaggregation of Revenue [Line Items]      
Concentration risk (percent) 17.90%    
Gross product revenue | Customer | McKesson Corporation      
Disaggregation of Revenue [Line Items]      
Concentration risk (percent) 15.40%    
IBSRELA      
Disaggregation of Revenue [Line Items]      
Revenue $ 500    
Product sales, net      
Disaggregation of Revenue [Line Items]      
Revenue $ 450 $ 0